BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28337768)

  • 21. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for
    Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC
    Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
    Sakata-Yanagimoto M
    Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
    Saillard C; Guermouche H; Derrieux C; Bruneau J; Frenzel L; Couronne L; Asnafi V; Macintyre E; Trinquand A; Lhermitte L; Molina T; Suarez F; Lemonnier F; Kosmider O; Delarue R; Hermine O; Cheminant M
    Hematol Oncol; 2017 Dec; 35(4):864-868. PubMed ID: 27353473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
    Dupuy A; Lemonnier F; Fataccioli V; Martin-Garcia N; Robe C; Pelletier R; Poullot E; Moktefi A; Mokhtari K; Rousselet MC; Traverse-Glehen A; Delarue R; Tournilhac O; Delfau-Larue MH; Haioun C; Ortonne N; Copie-Bergman C; de Leval L; Pujals A; Gaulard P
    J Mol Diagn; 2018 Sep; 20(5):677-685. PubMed ID: 29981867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.
    Attygalle A; Al-Jehani R; Diss TC; Munson P; Liu H; Du MQ; Isaacson PG; Dogan A
    Blood; 2002 Jan; 99(2):627-33. PubMed ID: 11781247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
    Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
    Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
    Fernandez-Pol S; Ma L; Joshi RP; Arber DA
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
    Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
    [No Abstract]   [Full Text] [Related]  

  • 31. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
    Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
    Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal germinal center B cells function as a niche for T-cell lymphoma.
    Fujisawa M; Nguyen TB; Abe Y; Suehara Y; Fukumoto K; Suma S; Makishima K; Kaneko C; Nguyen YTM; Usuki K; Narita K; Matsue K; Nakamura N; Ishikawa S; Miura F; Ito T; Suzuki A; Suzuki Y; Mizuno S; Takahashi S; Chiba S; Sakata-Yanagimoto M
    Blood; 2022 Nov; 140(18):1937-1950. PubMed ID: 35921527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.
    Ratajczak P; Leboeuf C; Wang L; Brière J; Loisel-Ferreira I; Thiéblemont C; Zhao WL; Janin A
    Mod Pathol; 2012 Jun; 25(6):805-14. PubMed ID: 22322190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
    Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
    Leuk Lymphoma; 2019 Dec; 60(13):3316-3319. PubMed ID: 31204875
    [No Abstract]   [Full Text] [Related]  

  • 35. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.
    Cortes JR; Ambesi-Impiombato A; Couronné L; Quinn SA; Kim CS; da Silva Almeida AC; West Z; Belver L; Martin MS; Scourzic L; Bhagat G; Bernard OA; Ferrando AA; Palomero T
    Cancer Cell; 2018 Feb; 33(2):259-273.e7. PubMed ID: 29398449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.
    Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N
    Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis].
    Guo YM; Liu XF; Jiao LJ; Yin SY; Wang Z; Li XX; Ma ZP; Yang JM; He MX
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):784-790. PubMed ID: 31594043
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression.
    Zhao WL; Mourah S; Mounier N; Leboeuf C; Daneshpouy ME; Legrès L; Meignin V; Oksenhendler E; Maignin CL; Calvo F; Brière J; Gisselbrecht C; Janin A
    Lab Invest; 2004 Nov; 84(11):1512-9. PubMed ID: 15311211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
    Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
    Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular diagnosis angioimmunoblastic T-cell lymphoma].
    Chernova NG; Sidorova YV; Smirnova SY; Ryzhikova NV; Nikulina EE; Kovrigina AM; Sinitsyna MN; Sudarikov AB
    Ter Arkh; 2019 Jul; 91(7):63-69. PubMed ID: 32598737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.